Answer
Ketorolac trometamol eye drops produce quite low systemic absorption in patients, with very low or undetectable plasma levels after ophthalmic dosing.
Sources for this answer
- AcularAbbVie Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 13Document updated
Sources checked